Evaluating Impact of Azithromycin Mass Drug Administrations on Cause-specific Mortality and Antibiotic Resistance: Mortality Trial
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Azithromycin (Primary)
- Indications Infections
- Focus Therapeutic Use
- Acronyms MORDOR
- 15 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 15 Mar 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 30 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.